2Curex
1 known investors
2cureX develops IndiTreat®, a 3D functional precision medicine test that grows patient-derived cancer cells as 3D microtumors (tumoroids) from a tumor biopsy to profile drug sensitivity and guide individualized therapy selection. The company serves oncologists and healthcare professionals, providing drug-response reports to inform cancer treatment decisions, and brings its diagnostic products through EU regulatory and reimbursement pathways.
Founders & leadership
OT
Ole ThastrupCEO, Founder and Board member
GH
Grith HagelVP Innovation, Co-Founder and Board member
KG
Kenneth Graabek JohansenCFO
JT
Jacob ThastrupCTO
Investors · 1
Frequently asked questions
- What does 2Curex do?
- 2cureX develops IndiTreat®, a 3D functional precision medicine test that grows patient-derived cancer cells as 3D microtumors (tumoroids) from a tumor biopsy to profile drug sensitivity and guide individualized therapy selection. The company serves oncologists and healthcare professionals, providing drug-response reports to inform cancer treatment decisions, and brings its diagnostic products through EU regulatory and reimbursement pathways.
- Who founded 2Curex?
- 2Curex was founded by Ole Thastrup, Grith Hagel.
- Who are 2Curex's investors?
- 2Curex's investors include Kinled Holding.